Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.355 USD | -0.65% |
|
+6.66% | +47.39% |
Jun. 22 | MannKind Corporation Announces Positive 17-Week Results from the INHALE-3 Study | CI |
May. 29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
- Stock Market
- Equities
- MNKD Stock
- News MannKind Corporation